Vertex Pharmaceuticals (VRTX)
S&P 500 · Nasdaq-100 · Health Care · data since 1991-07-24 · last close 2026-07-24
1d
+0.90%
7d
-1.71%
30d
+0.45%
YTD
+5.29%
1y
+1.08%
Vertex Pharmaceuticals (VRTX) monthly returns (%)
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.6 | 5.7 | -10.1 | -4.3 | 4.7 | 11.0 | -3.9 | · | · | · | · | · |
| 2025 | 14.7 | 3.9 | 1.1 | 5.1 | -13.2 | 0.7 | 2.6 | -14.4 | 0.2 | 8.7 | 1.9 | 4.5 |
| 2024 | 6.5 | -2.9 | -0.7 | -6.0 | 15.9 | 2.9 | 5.8 | 0.0 | -6.2 | 2.3 | -1.6 | -14.0 |
| 2023 | 11.9 | -10.2 | 8.5 | 8.1 | -5.0 | 8.8 | 0.1 | -1.1 | -0.2 | 4.1 | -2.0 | 14.7 |
| 2022 | 10.7 | -5.4 | 13.5 | 4.7 | -1.7 | 4.9 | -0.5 | 0.5 | 2.8 | 7.8 | 1.4 | -8.7 |
| 2021 | -3.1 | -7.2 | 1.1 | 1.5 | -4.4 | -3.4 | -0.0 | -0.6 | -9.4 | 1.9 | 1.1 | 17.5 |
| 2020 | 3.7 | -1.3 | 6.2 | 5.6 | 14.6 | 0.8 | -6.3 | 2.6 | -2.5 | -23.4 | 9.3 | 3.8 |
| 2019 | 15.2 | -1.1 | -2.5 | -8.1 | -1.7 | 10.3 | -9.1 | 8.0 | -5.9 | 15.4 | 13.4 | -1.3 |
| 2018 | 11.3 | -0.5 | -1.8 | -6.0 | 0.6 | 10.4 | 3.0 | 5.3 | 4.5 | -12.1 | 6.7 | -8.3 |
| 2017 | 16.6 | 5.5 | 20.7 | 8.2 | 4.5 | 4.3 | 17.8 | 5.7 | -5.3 | -3.8 | -1.3 | 3.9 |
| 2016 | -27.9 | -5.8 | -7.0 | 6.1 | 10.4 | -7.7 | 12.8 | -2.6 | -7.7 | -13.0 | 7.6 | -9.7 |
| 2015 | -7.3 | 8.4 | -1.2 | 4.5 | 4.1 | -3.8 | 9.3 | -5.5 | -18.3 | 19.8 | 3.7 | -2.7 |
| 2014 | 6.4 | 2.3 | -12.5 | -4.3 | 6.7 | 31.0 | -6.1 | 5.2 | 20.0 | 0.3 | 4.7 | 0.8 |
| 2013 | 6.9 | 4.6 | 17.4 | 39.8 | 4.6 | -0.3 | -0.3 | -5.8 | 0.9 | -5.9 | -2.7 | 7.0 |
| 2012 | 11.3 | 5.3 | 5.4 | -6.2 | 56.0 | -6.9 | -13.3 | 9.9 | 4.8 | -13.6 | -17.6 | 5.3 |
| 2011 | 11.0 | 20.0 | 2.7 | 14.8 | -1.9 | -3.7 | -0.3 | -12.7 | -1.8 | -10.9 | -26.8 | 14.6 |
| 2010 | -10.4 | 5.6 | 0.8 | -5.1 | -10.8 | -4.9 | 2.3 | -1.0 | 3.8 | 10.8 | -13.5 | 5.7 |
| 2009 | 8.8 | -8.8 | -4.7 | 7.3 | -3.4 | 20.8 | 0.1 | 3.9 | 1.3 | -11.4 | 15.7 | 10.4 |
| 2008 | -12.3 | -14.1 | 36.5 | 6.8 | 12.2 | 16.9 | 3.1 | -22.1 | 23.8 | -21.1 | -6.2 | 23.6 |
| 2007 | -5.5 | -13.2 | -8.6 | 9.6 | -2.7 | -4.5 | 13.1 | 20.6 | -1.4 | -15.8 | -21.5 | -8.5 |
| 2006 | 29.1 | 21.1 | -15.4 | -0.6 | -5.1 | 6.4 | -8.7 | 2.8 | -2.3 | 20.6 | 9.1 | -15.5 |
| 2005 | -3.8 | 13.5 | -18.9 | 1.8 | 46.1 | 21.1 | -5.3 | 15.4 | 21.5 | 1.8 | 12.1 | 8.5 |
| 2004 | -4.3 | 13.7 | -16.4 | -8.3 | 1.9 | 23.2 | -14.8 | 5.4 | 7.9 | 3.6 | -2.4 | -0.5 |
| 2003 | -12.7 | -20.2 | 0.8 | 8.3 | 20.2 | 0.9 | -0.7 | -13.3 | -2.4 | 6.7 | -33.4 | 18.4 |
| 2002 | -19.7 | 10.5 | 27.7 | -23.6 | -7.2 | -17.5 | 21.3 | 0.8 | -7.1 | 6.1 | -5.3 | -14.7 |
| 2001 | -5.9 | -26.1 | -26.4 | 5.3 | 13.9 | 12.7 | -19.3 | -7.7 | -51.1 | 35.8 | 3.3 | -2.8 |
| 2000 | 17.1 | 77.1 | -35.5 | 11.6 | 41.4 | 42.6 | -7.1 | 73.6 | -0.6 | 10.2 | -40.0 | 28.0 |
| 1999 | 5.9 | -25.4 | 7.5 | -16.3 | -5.0 | 20.3 | 4.7 | 9.9 | 11.9 | -7.8 | -7.2 | 31.8 |
| 1998 | 18.9 | -4.8 | -14.6 | -2.5 | -7.6 | -21.7 | -7.2 | -26.9 | 50.8 | 14.7 | -10.2 | 25.6 |
| 1997 | 21.7 | -5.6 | -12.4 | -21.6 | 27.6 | -5.6 | -8.2 | -2.5 | 10.2 | -21.9 | -6.1 | 19.2 |
| 1996 | 1.9 | 2.8 | -4.5 | 10.4 | 27.4 | -18.5 | -18.5 | 28.3 | -7.1 | 12.7 | -3.0 | 24.8 |
| 1995 | 3.3 | 4.8 | -16.9 | 5.6 | 10.5 | 4.0 | 3.0 | 23.0 | -9.6 | -12.0 | 25.0 | 28.5 |
| 1994 | 2.7 | -10.5 | -21.3 | 1.9 | -6.4 | -3.9 | -8.2 | 27.8 | -0.9 | -7.9 | 4.8 | 9.1 |
| 1993 | 2.6 | -25.0 | 6.7 | 3.1 | 39.4 | -17.4 | 2.6 | 2.6 | 27.5 | 17.6 | 6.7 | 15.6 |
| 1992 | -8.5 | -11.1 | -2.1 | 0.0 | -17.0 | -23.1 | 13.3 | 11.8 | 11.8 | -15.3 | 25.0 | -13.3 |
| 1991 | · | · | · | · | · | · | 0.0 | 15.3 | 42.2 | -1.7 | -21.6 | 29.7 |
| Avg | 3.4 | 0.2 | -2.2 | 1.6 | 7.7 | 3.2 | -0.6 | 4.6 | 3.0 | 0.1 | -2.0 | 7.2 |
Values in %. Current and first-listed months are partial (greyed).
returnsview.com
Seasonality — average by calendar month
| Month | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg | +3.4% | +0.2% | -2.2% | +1.6% | +7.7% | +3.2% | -0.5% | +4.6% | +3.0% | +0.1% | -2.0% | +7.2% |
| Win rate | 66%/35 | 46%/35 | 43%/35 | 60%/35 | 57%/35 | 57%/35 | 46%/35 | 63%/35 | 49%/35 | 54%/35 | 49%/35 | 66%/35 |
Win rate = share of positive months / sample size.
Risk & extremes
Max drawdown
-91.8%
Worst peak-to-trough fall on record
Monthly volatility
±14.9%
Std. dev. of monthly returns
Positive months
55%
Share of completed months in the green
Best month
+77.13%
2000-02
Worst month
-51.1%
2001-09
Longest streaks
8▲ / 7▼
Consecutive up / down months
Drawdown & rolling returns
Percent below the all-time high at each month-end — how far underwater the asset was.
About Vertex Pharmaceuticals
Vertex Pharmaceuticals turns lab coats into cash flows — with price receipts on this site going back to 1991. And the long game: $100 at its first close here (1991) would be about $11,037 today.
Did you know?
- Its best month on record was February 2000 at +77.13%; its worst, September 2001 at -51.1%.
Trivia for entertainment — the numbers come from our price data; the jokes don't.